Spotlight: Giancarlo Agnelli, MD. Interview by Emma Baines.
Agnelli
Giancarlo
G
D000925:Anticoagulants / Q000009:adverse effects / Q000266:history / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000266:history / Q000378:metabolism; D035843:Biomedical Research / Q000266:history / Q000379:methods; D006470:Hemorrhage / Q000139:chemically induced / Q000266:history / Q000378:metabolism; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007558:Italy; D008991:Monitoring, Physiologic / Q000266:history / Q000379:methods; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000266:history / Q000378:metabolism; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000266:history / Q000378:metabolism; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000266:history
D000925:Anticoagulants